Logo
I

ImmunoMind.

15 employees

Multi-Omics Driven Development of Effective Cell Therapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Immunogenomics
Single-cell transcriptomics
Biotech
Adoptive T-cell therapy
Deep Learning
Precision medicine
Bioinformatics
Therapeutics
Immunology
CAR-T
CAR-NKT
Genetics
Single-cell
Engineered TCR

Date founded

2020

Funding rounds raised

Total raised

$105K

from 1 investors over 1 rounds

I

ImmunoMind. raised $105K on March 12, 2020

Investors: Berkeley SkyDeck

FAQ